Live Breaking News & Updates on Company Breast Products Segment
Stay updated with breaking news from Company breast products segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Sientra Announces Pricing of Public Offering of Common Stock Sientra, Inc.February 9, 2021 GMT SANTA BARBARA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced the pricing of its previously announced underwritten public offering. The Company will sell 5,410,628 shares of its common stock at a public offering price of $6.75 per share. The gross proceeds to Sientra, before deducting the underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $36.5 million. The offering is expected to close on or about February 11, 2021, subject to customary closing conditions. In addition, the Company has granted the underwriters a 30-day option to purchase up to 811,594 additional shares at the public offer ....
Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth Results driven by Sientra’s continued investment and market outperformance in the core breast products segment SANTA BARBARA, Calif., Feb. 04, 2021 Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2020. Ron Menezes, President and Chief Executive Officer of Sientra, stated, “As the only breast aesthetics company committed exclusively to the plastic surgery channel, Sientra is focused on becoming the leader in novel treatments that progress the art of plastic surgery. Throughout 2020, Sientra increased investment in our breast aesthetics business, expanding our salesforce and product ....
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results Sientra, Inc.February 4, 2021 GMT Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth Results driven by Sientra’s continued investment and market outperformance in the core breast products segment SANTA BARBARA, Calif., Feb. 04, 2021 (GLOBE NEWSWIRE) Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2020. ....